Literature DB >> 782458

Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.

D Farquhar, T L Loo, J U Gutterman, E M Hersh, M A Luna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 782458     DOI： 10.1016/0006-2952(76)90072-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  Interaction between immunologic and chemotherapeutic treatments.

Authors:  P W Mullen
Journal:  Can Med Assoc J       Date:  1982-10-01       Impact factor: 8.262

3.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

4.  Depression of theophylline elimination following BCG vaccination.

Authors:  J D Gray; K W Renton; O R Hung
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

5.  Influence of trivalent influenza vaccine on serum theophylline levels.

Authors:  R G Fischer; B H Booth; D Q Mitchell; A H Kibbe
Journal:  Can Med Assoc J       Date:  1982-06-01       Impact factor: 8.262

6.  Pharmacokinetics of phenytoin and liver cytochrome P-450 levels in mice after single doses of Corynebacterium parvum [proceedings].

Authors:  P W Mullen
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

7.  Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients.

Authors:  G G Chabot; L E Flaherty; M Valdivieso; L H Baker
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  A study of maternal lymphoid organs and the progeny following treatment with immunomodulating agents during pregnancy.

Authors:  J R Scott; T L Feldbush; J M Covault
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

9.  Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors:  H Breithaupt; A Dammann; K Aigner
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

10.  Type II interferon induction and passive transfer depress the murine cytochrome P-450 drug metabolism system.

Authors:  G Sonnenfeld; C L Harned; S Thaniyavarn; T Huff; A D Mandel; D E Nerland
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.